Skip to main content
Clinical Trials/NL-OMON43187
NL-OMON43187
Withdrawn
Not Applicable

Efficacy of vitamin D supplementation in preventing peripheral neuropathy in multiple myeloma patients. - Efficacy of vitamin D in preventing neuropathy

Medisch Centrum Leeuwarden0 sites52 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral neuropathy
Sponsor
Medisch Centrum Leeuwarden
Enrollment
52
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Centrum Leeuwarden

Eligibility Criteria

Inclusion Criteria

  • Patients with multiple myeloma with grade 2/3 peripheral neuropathy and a 25\-hydroxyvitamin D level \<75 nmol/l.

Exclusion Criteria

  • Contraindications for the use of vitamin D and/or patients who are already using any formulation of vitamin D

Outcomes

Primary Outcomes

Not specified

Similar Trials